1-3 of 3
Kathleen McKeever
Close
Sort by
Journal Articles

A microRNA Signature Predicts Response to Anti-CD19 Therapy (MEDI-551) in B-Cell Malignancies

Katie Streicher, PhD, Philip Brohawn, Mike Kuziora, Fernanda Pilataxi, Brandon Higgs, Kim Lehmann, Kathleen McKeever, Trishna Goswami, MD, Ronald Herbst, PhD, Yihong Yao, Koustubh Ranade
Journal: Blood
Blood (2014) 124 (21): 2198.
https://doi.org/10.1182/blood.V124.21.2198.2198
Published: 2014
Journal Articles

Antibody-Drug Conjugates with Uncleavable Linkers for the Treatment of Non-Hodgkin Lymphoma.

Andrew G. Polson, PhD, Suzanna Clark, Changchun Du, Dan Eaton, Ph.D., Kristi Elkins, Reina N. Fuji, VMD, PhD, Mary Ann, Go, Alane Gray, Tom Januario, Hartmut Koeppen, M.D., Ph.D., Jeffery Lau, Will Leach, Elena McDorman, Ph.D., Kathleen McKeever, Ph.D., Saileta Prabhu, Ph.D., Suzie J. Scales, Ph.D., Dionysos Slaga, Susan Spencer, Marna Williams, Ph.D, David Xie, Shang-Fan Yu, Bing Zheng, Allen Ebens, PhD.
Journal: Blood
Blood (2007) 110 (11): 526.
https://doi.org/10.1182/blood.V110.11.526.526
Published: 2007
Journal Articles

Pharmacokinetics of Anti-CD22 Antibody Conjugates with Uncleavable and Cleavable Linkers in Rats.

Dong Xie, Rong Deng, Jakub Baudys, Pam Chan, Randy Dere, Allen Ebens, Paul Fielder, Reina Fuji, Alane Gray, Catherine Hung, Suhas Iyer, Kathleen McKeever, Margaret Kenrick, Will Leach, Andrew Polson, Ola Saad, Jean-Philippe Stephan, Ben Quan Shen, Jay Tibbitts, Shang-Fan Yu, Saileta Prabhu
Journal: Blood
Blood (2007) 110 (11): 2361.
https://doi.org/10.1182/blood.V110.11.2361.2361
Published: 2007